Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India

We investigated the prevalence of vulvovaginal candidiasis due to C. africana in an STD clinic in India and analysed the genetic relatedness of these C. africana isolates with those outside India. A total of 283 germ‐tube‐positive yeasts were identified by VITEK2. Molecular characterisation of all isolates was carried out by hwp1‐gene‐specific PCR. Of 283 germ‐tube‐positive yeast isolates, four were identified as C. africana using hwp1‐gene‐specific PCR. All hwp1 PCR positive C. africana were subjected to antifungal susceptibility testing, ITS and D1/D2 region sequencing and were typed by using MLST approach. Similar to C. africana isolates from the United Kingdom and unlike those from Africa, the Indian C. africana grew at 42°C. Sequencing of eight gene fragments in MLST identified all four strains to have different genotypes not reported previously. Furthermore, though the Indian C. africana isolates were susceptible to most of the 14 tested antifungal drugs, differences in susceptibility were observed among the four strains. Our results indicate genetic and phenotypic heterogeneity among C. africana from different geographical regions. Due to lack of data on epidemiology and genetic variability of this under‐reported yeast, more studies using molecular methods are warranted.

[1]  T. Khaithir,et al.  Issues in Identifying Germ Tube Positive Yeasts by Conventional Methods , 2014, Journal of clinical laboratory analysis.

[2]  G. Criseo,et al.  Candida africana: Is It a Fungal Pathogen? , 2013, Current Fungal Infection Reports.

[3]  A. Chowdhary,et al.  Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India. , 2013, Diagnostic microbiology and infectious disease.

[4]  A. Borman,et al.  Epidemiology, Antifungal Susceptibility, and Pathogenicity of Candida africana Isolates from the United Kingdom , 2013, Journal of Clinical Microbiology.

[5]  O. Gaye,et al.  Identification de trois souches de Candida africana au Sénégal , 2012 .

[6]  N. E. Nnadi,et al.  Isolation and molecular characterization of Candida africana from Jos, Nigeria. , 2012, Medical mycology.

[7]  G. Criseo,et al.  Candida africana and its closest relatives , 2011, Mycoses.

[8]  G. Criseo,et al.  Adherence ability of Candida africana: a comparative study with Candida albicans and Candida dubliniensis , 2011, Mycoses.

[9]  M. Ilkit,et al.  Lack of Candida africana and Candida dubliniensis in Vaginal Candida albicans Isolates in Turkey Using HWP1 Gene Polymorphisms , 2011, Mycopathologia.

[10]  G. Criseo,et al.  Morphological, biochemical and molecular characterisation of the first Italian Candida africana isolate , 2009, Mycoses.

[11]  C. Pais,et al.  Increased number of glutamine repeats in the C-terminal of Candida albicans Rlm1p enhances the resistance to stress agents , 2009, Antonie van Leeuwenhoek.

[12]  G. Criseo,et al.  Molecular Epidemiology of Candida albicans and Its Closely Related Yeasts Candida dubliniensis and Candida africana , 2008, Journal of Clinical Microbiology.

[13]  G. Criseo,et al.  First molecular method for discriminating between Candida africana, Candida albicans, and Candida dubliniensis by using hwp1 gene. , 2008, Diagnostic microbiology and infectious disease.

[14]  M. Jacobsen,et al.  Multilocus Sequence Typing of Pathogenic Candida Species , 2008 .

[15]  J. Guarro,et al.  Isolation of Candida africana, probable atypical strains of Candida albicans, from a patient with vaginitis. , 2008, Medical mycology.

[16]  D. Diogo,et al.  Molecular Phylogenetics of Candida albicans , 2007, Eukaryotic Cell.

[17]  A. Chowdhary,et al.  Comparison of multilocus sequence typing and Ca3 fingerprinting for molecular subtyping epidemiologically-related clinical isolates of Candida albicans. , 2006, Medical mycology.

[18]  E. Böttger,et al.  Internal Transcribed Spacer Sequencing versus Biochemical Profiling for Identification of Medically Important Yeasts , 2006, Journal of Clinical Microbiology.

[19]  W. Mendling,et al.  A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten®, two formats) with oral single dose fluconazole (Diflucan®) in vulvovaginal mycoses , 2004, Mycoses.

[20]  M. Maiden,et al.  Collaborative Consensus for Optimized Multilocus Sequence Typing of Candida albicans , 2003, Journal of Clinical Microbiology.

[21]  M. Maiden,et al.  Optimization and Validation of Multilocus Sequence Typing for Candida albicans , 2003, Journal of Clinical Microbiology.

[22]  W. Sterry,et al.  Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? , 2001, Mycoses.

[23]  T. G. Mitchell,et al.  Genetic structure of typical and atypical populations of Candida albicans from Africa. , 1999, Fungal genetics and biology : FG & B.

[24]  C. Kurtzman,et al.  Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene , 1997, Journal of clinical microbiology.

[25]  G. Schönian,et al.  Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa , 1995, Journal of clinical microbiology.

[26]  O. Gaye,et al.  [Identification of three Candida africana strains in Senegal]. , 2012, Journal de mycologie medicale.

[27]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[28]  S. Al-Hedaithy,et al.  Recovery and studies on chlamydospore-negative Candida albicans isolated from clinical specimens. , 2002, Medical mycology.

[29]  D. Swofford PAUP*: Phylogenetic analysis using parsimony (*and other methods), Version 4.0b10 , 2002 .

[30]  T. White Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .